AMG 531, a Thrombopoiesis-Stimulating Protein, for Chronic ITPJames B. Bussel, Janet L. Nichol, Louis M. Aledort et al.|New England Journal of Medicine|2006Cited by 530
A Phase 2 Placebo Controlled Study Evaluating the Platelet Response and Safety of Weekly Dosing with a Novel Thrombopoietic Protein (AMG531) in Thrombocytopenic Adult Patients (pts) with Immune Thrombocytopenic Purpura (ITP).David J. Kuter, Janet L. Nichol, James B. Bussel et al.|Blood|2004Cited by 17